| Trial ID: | L1211 |
| Source ID: | NCT00745199
|
| Associated Drug: |
Cromolyn Sodium
|
| Title: |
Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease|Pruritus
|
| Interventions: |
DRUG: cromolyn sodium|DRUG: placebo
|
| Outcome Measures: |
Primary: pruritus, 3 months | Secondary: serum tryptase level, 4 months
|
| Sponsor/Collaborators: |
Sponsor: Shiraz University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
62
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2009-06
|
| Results First Posted: |
|
| Last Update Posted: |
2009-08-18
|
| Locations: |
Shiraz University of Medical sciences, Nemazi and Faghihi Hospital, Shiraz, Fars, 71345, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00745199
|
